NCT05192603 is a NA clinical trial of low FODMAP or SSRD in IBS - Irritable Bowel Syndrome, sponsored by Region Skane.

Who is sponsoring NCT05192603?

NCT05192603 is sponsored by Region Skane.

What drugs are being tested in NCT05192603?

Interventions in NCT05192603: low FODMAP or SSRD.

What condition does NCT05192603 study?

NCT05192603 studies IBS - Irritable Bowel Syndrome.

Is NCT05192603 still recruiting?

NCT05192603 is currently enrolling by invitation. Last updated 9 December 2025.

Last reviewed 2025-12-09 · How we verify

NCT05192603

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Low FODMAP and SSRD in IBS

ENROLLING BY INVITATION NA Last updated 9 December 2025

What this trial tests

NA trial testing low FODMAP or SSRD in IBS - Irritable Bowel Syndrome in 200 participants. Enrolling by invitation.

Timeline

1 March 2022

Primary endpoint
13 February 2024

31 March 2029

Quick facts

Lead sponsor	Region Skane
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	1 March 2022
Primary completion	13 February 2024
Estimated completion	31 March 2029
Sites	1 location across Sweden

Drugs / interventions tested

low FODMAP or SSRD

Conditions studied

IBS - Irritable Bowel Syndrome — all drugs for IBS - Irritable Bowel Syndrome →

Sponsor

Region Skane — full company profile →

Who can join

Adults 18 to 70, any sex, with IBS - Irritable Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to compare the efficiency of low FODMAP and SSRD to reduce symptoms in IBS, and to study the mechanisms and consequences of the two diets.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study.
Roth B, Nseir M, Jeppsson H, D'Amato M, et al · · 2024 · cited 13× · PMID 39275354 · DOI 10.3390/nu16173039
Challenges of recruitment processes to a randomized dietary trial in irritable bowel syndrome.
Roth B, Ohlsson B. · · 2024 · cited 9× · PMID 38939366 · DOI 10.12688/f1000research.147710.2
Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study.
Roth B, Ohlsson B. · · 2024 · cited 7× · PMID 39227769 · DOI 10.1186/s12876-024-03373-x
Leptin and PAI-1 Levels Are Decreased After a Dietary Intervention in Patients with Irritable Bowel Syndrome.
Szekely AB, Nseir M, Roth B, Ohlsson B. · · 2025 · cited 2× · PMID 40429752 · DOI 10.3390/ijms26104607
Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials.
Roth B, Ohlsson B. · · 2025 · cited 1× · PMID 41010496 · DOI 10.3390/nu17182966
Challenges of recruitment processes to a randomized dietary trial in irritable bowel syndrome [version 2; peer review: 2 approved]
Roth B, Ohlsson B. · · 2024
Challenges of recruitment processes to a randomized dietary trial in irritable bowel syndrome
Roth B, Ohlsson B. · · 2024 · DOI 10.12688/f1000research.147710.2

Verify or expand the search:

Other recruiting trials for IBS - Irritable Bowel Syndrome

Currently open trials in the same condition.

NCT06993272 — Relaxation Music for Chronic Pain · NA · active not recruiting
NCT06684470 — Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodul · EARLY_PHASE1 · recruiting
NCT06117865 — Digital Treatment of Irritable Bowel Syndrome (IBS) · NA · active not recruiting
NCT06215222 — Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease · recruiting
NCT05815602 — Ebastine Versus Mebeverine in IBS Patients · Phase 3 · recruiting

Other Region Skane trials

Trials by the same sponsor.

NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
NCT07494669 — Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery · not yet recruiting
NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05192603 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region Skane
Last refreshed: 9 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05192603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing